K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797
E.W. Gilbert, R.A. Luna, V.L. Harrison, and J.G. Hunter Barrett's esophagus: a review of the literature J Gastrointest Surg 15 2011 708 718
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
Y.V. Bobryshev, D. Tran, M.C. Killingsworth, M. Buckland, and R.V. Lord Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma J Gastrointest Surg 13 2009 44 53
H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146
L.M. Moons, J.G. Kusters, E. Bultman, E.J. Kuipers, H. van Dekken, W.M. Tra, A. Kleinjan, J. Kwekkeboom, A.H. van Vliet, and P.D. Siersema Barrett's oesophagus is characterized by a predominantly humoral inflammatory response J Pathol 207 2005 269 276
B.J. Colleypriest, S.G. Ward, and D. Tosh How does inflammation cause Barrett's metaplasia? Curr Opin Pharmacol 9 2009 721 726
G.T. Belz, and S.L. Nutt Transcriptional programming of the dendritic cell network Nat Rev Immunol 12 2012 101 113
P. Middel, S. Brauneck, W. Meyer, and H.J. Radzun Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma BMC Cancer 10 2010 578
S. Gregory, M. Zilber, D. Charron, and C. Gelin Human CD1a molecule expressed on monocytes plays an accessory role in the superantigen-induced activation of T lymphocytes Hum Immunol 61 2000 193 201
L. Krenacs, L. Tiszalvicz, T. Krenacs, and L. Boumsell Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010 J Pathol 171 1993 99 104
S. Gregori Dendritic cells in networks of immunological tolerance Tissue Antigens 77 2011 89 99
D.R. Greaves, W. Wang, D.J. Dairaghi, M.C. Dieu, B. Saint-Vis, K. Franz-Bacon, D. Rossi, C. Caux, T. McClanahan, S. Gordon, A. Zlotnik, and T.J. Schall CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells J Exp Med 186 1997 837 844
C. Caux, S. Ait-Yahia, K. Chemin, O. de Bouteiller, M.C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, and A. Vicari Dendritic cell biology and regulation of dendritic cell trafficking by chemokines Springer Semin Immunopathol 22 2000 345 369
C. Ardavin, G. Martinez del Hoyo, P. Martin, F. Anjuere, C.F. Arias, A.R. Marin, S. Ruiz, V. Parrillas, and H. Hernandez Origin and differentiation of dendritic cells Trends Immunol 22 2001 691 700
C. Caux, C. Massacrier, B. Vanbervliet, B. Dubois, B. de Saint-Vis, C. Dezutter-Dambuyant, C. Jacquet, D. Schmitt, and J. Banchereau CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha Adv Exp Med Biol 417 1997 21 25
J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767 811
A. Lanzavecchia, and F. Sallusto Regulation of T cell immunity by dendritic cells Cell 106 2001 263 266
A. Dzionek, Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Gunther, I. Johnston, A. Lanzavecchia, T. Nagasaka, T. Okada, W. Vermi, G. Winkels, T. Yamamoto, M. Zysk, Y. Yamaguchi, and J. Schmitz BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction J Exp Med 194 2001 1823 1834
M. Swiecki, and M. Colonna Accumulation of plasmacytoid DC: roles in disease pathogenesis and targets for immunotherapy Eur J Immunol 40 2010 2094 2098
B. Bondue, V. Wittamer, and M. Parmentier Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism Cytokine Growth Factor Rev 22 2011 331 338
S. Demoulin, M. Herfs, P. Delvenne, and P. Hubert Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms J Leukoc Biol 93 2013 343 352
N. Halama, S. Michel, M. Kloor, I. Zoernig, T. Pommerencke, M. von Knebel Doeberitz, P. Schirmacher, J. Weitz, N. Grabe, and D. Jager The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy Cancer Immun 9 2009 1
F. Pages, J. Galon, M.C. Dieu-Nosjean, E. Tartour, C. Sautes-Fridman, and W.H. Fridman Immune infiltration in human tumors: a prognostic factor that should not be ignored Oncogene 29 2010 1093 1102
G. Gerlini, C. Urso, G. Mariotti, P. Di Gennaro, D. Palli, P. Brandani, A. Salvadori, N. Pimpinelli, U.M. Reali, and L. Borgognoni Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes Clin Immunol 125 2007 184 193
E. Hartmann, B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, and G. Hartmann Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer Cancer Res 63 2003 6478 6487
S.I. Labidi-Galy, I. Treilleux, S. Goddard-Leon, J.D. Combes, J.Y. Blay, I. Ray-Coquard, C. Caux, and N. Bendriss-Vermare Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis Oncoimmunology 1 2012 380 382
V. Sisirak, J. Faget, M. Gobert, N. Goutagny, N. Vey, I. Treilleux, S. Renaudineau, G. Poyet, S.I. Labidi-Galy, S. Goddard-Leon, I. Durand, I. Le Mercier, A. Bajard, T. Bachelot, A. Puisieux, I. Puisieux, J.Y. Blay, C. Ménétrier-Caux, C. Caux, and N. Bendriss-Vermare Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression Cancer Res 72 2012 5188 5197
A. Faith, E. Peek, J. McDonald, Z. Urry, D.F. Richards, C. Tan, G. Santis, and C. Hawrylowicz Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses Am J Respir Cell Mol Biol 36 2007 360 367
L. Yang, and D.P. Carbone Tumor-host immune interactions and dendritic cell dysfunction Adv Cancer Res 92 2004 13 27
S.K. Watkins, Z. Zhu, E. Riboldi, K.A. Shafer-Weaver, K.E. Stagliano, M.M. Sklavos, S. Ambs, H. Yagita, and A.A. Hurwitz FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer J Clin Invest 121 2011 1361 1372
M.K. Brimnes, I.M. Svane, and H.E. Johnsen Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma Clin Exp Immunol 144 2006 76 84
Y. Hirohashi, and N. Sato Tumor-associated dendritic cells: molecular mechanisms to suppress antitumor immunity Immunotherapy 3 2011 945 947
P. Hubert, J.H. Caberg, C. Gilles, L. Bousarghin, E. Franzen-Detrooz, J. Boniver, and P. Delvenne E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions J Pathol 206 2005 346 355
L. Herman, P. Hubert, M. Herfs, G. Kustermans, Y. Henrotin, L. Bousarghin, J. Boniver, and P. Delvenne The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context Eur J Immunol 40 2010 3075 3084
S. Demoulin, P. Roncarati, P. Delvenne, and P. Hubert Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34(+) hematopoietic progenitor cells: use of interleukin-3 Exp Hematol 40 2012 268 278
D. Hawiger, K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J Exp Med 194 2001 769 779
P. Delvenne, P. Hubert, and N. Jacobs Epithelial metaplasia: an inadequate environment for antitumour immunity? Trends Immunol 25 2004 169 173
R.C. Fitzgerald, S. Abdalla, B.A. Onwuegbusi, P. Sirieix, I.T. Saeed, W.R. Burnham, and M.J. Farthing Inflammatory gradient in Barrett's oesophagus: implications for disease complications Gut 51 2002 316 322
M. Kornete, and C.A. Piccirillo Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance Front Immunol 3 2012 165
B.M. Matta, A. Castellaneta, and A.W. Thomson Tolerogenic plasmacytoid DC Eur J Immunol 40 2010 2667 2676
S. Manicassamy, and B. Pulendran Dendritic cell control of tolerogenic responses Immunol Rev 241 2011 206 227
N. Janikashvili, B. Bonnotte, E. Katsanis, and N. Larmonier The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance Clin Dev Immunol 2011 2011 430394
C. Albanesi, C. Scarponi, S. Pallotta, R. Daniele, D. Bosisio, S. Madonna, P. Fortugno, S. Gonzalvo-Feo, J.D. Franssen, M. Parmentier, O. De Pita, G. Girolomoni, and S. Sozzani Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment J Exp Med 206 2009 249 258
B.P. Wijnhoven, H.W. Tilanus, and W.N. Dinjens Molecular biology of Barrett's adenocarcinoma Ann Surg 233 2001 322 337
M. Saraiva, and A. O'Garra The regulation of IL-10 production by immune cells Nat Rev Immunol 10 2010 170 181
M. Chieppa, G. Bianchi, A. Doni, A. Del Prete, M. Sironi, G. Laskarin, P. Monti, L. Piemonti, A. Biondi, A. Mantovani, M. Introna, and P. Allavena Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program J Immunol 171 2003 4552 4560
M. Herfs, L. Herman, P. Hubert, F. Minner, M. Arafa, P. Roncarati, Y. Henrotin, J. Boniver, and P. Delvenne High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells Cancer Immunol Immunother 58 2009 603 614
A.J. Troy, K.L. Summers, P.J. Davidson, C.H. Atkinson, and D.N. Hart Minimal recruitment and activation of dendritic cells within renal cell carcinoma Clin Cancer Res 4 1998 585 593
A.J. Troy, P.J. Davidson, C.H. Atkinson, and D.N. Hart CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated J Urol 161 1999 1962 1967
D.I. Gabrilovich, J. Corak, I.F. Ciernik, D. Kavanaugh, and D.P. Carbone Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 3 1997 483 490
A.H. Enk, H. Jonuleit, J. Saloga, and J. Knop Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma Int J Cancer 73 1997 309 316
K.J. Chen, S.Z. Lin, L. Zhou, H.Y. Xie, W.H. Zhou, A. Taki-Eldin, and S.S. Zheng Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis PLoS One 6 2011 e24671
T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser Effect of interleukin-10 on dendritic cell maturation and function Eur J Immunol 27 1997 1229 1235
K. Loser, A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J.M. Penninger, and S. Beissert Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells Nat Med 12 2006 1372 1379
T. Totsuka, T. Kanai, Y. Nemoto, T. Tomita, R. Okamoto, K. Tsuchiya, T. Nakamura, N. Sakamoto, H. Akiba, K. Okumura, H. Yagita, and M. Watanabe RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis J Immunol 182 2009 6079 6087
E.A. Green, Y. Choi, and R.A. Flavell Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals Immunity 16 2002 183 191
K. Steinbrink, M. Wolfl, H. Jonuleit, J. Knop, and A.H. Enk Induction of tolerance by IL-10-treated dendritic cells J Immunol 159 1997 4772 4780
A. Leibbrandt, and J.M. Penninger TNF conference 2009: beyond bones - RANKL/RANK in the immune system Adv Exp Med Biol 691 2011 5 22
B. Franz, B. Fritzsching, A. Riehl, N. Oberle, C.D. Klemke, J. Sykora, S. Quick, C. Stumpf, M. Hartmann, A. Enk, T. Ruzicka, P.H. Krammer, E. Suri-Payer, and A. Kuhn Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus Arthritis Rheum 56 2007 1910 1920
I. Silva, and J.C. Branco Rank/Rankl/opg: literature review Acta Reumatol Port 36 2011 209 218
S. Hegde, J. Pahne, and S. Smola-Hess Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression FASEB J 18 2004 1439 1441
G.V. Shurin, M.R. Shurin, S. Bykovskaia, J. Shogan, M.T. Lotze, and E.M. Barksdale Jr. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function Cancer Res 61 2001 363 369
C.A. Carlos, H.F. Dong, O.M. Howard, J.J. Oppenheim, F.G. Hanisch, and O.J. Finn Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity J Immunol 175 2005 1628 1635
B.S. Kaur, and G. Triadafilopoulos Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent Am J Physiol Gastrointest Liver Physiol 283 2002 G327 G334
S.C. Burjonrappa, S. Reddimasu, Z. Nawaz, X. Gao, P. Sharma, and B. Loggie Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus Indian J Cancer 44 2007 1 5
F. Milano, and K.K. Krishnadath Novel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens Hum Immunol 69 2008 614 624
P. Monti, B.E. Leone, A. Zerbi, G. Balzano, S. Cainarca, V. Sordi, M. Pontillo, A. Mercalli, V. Di Carlo, P. Allavena, and L. Piemonti Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell J Immunol 172 2004 7341 7349
M. Loos, R. Langer, T. Schuster, R. Gertler, A. Walch, S. Rauser, H. Friess, and M. Feith Clinical significance of the costimulatory molecule B7-H1 in Barrett carcinoma Ann Thorac Surg 91 2011 1025 1031
